|
|
maintenance of cell number
|
GO:0098727 |
3 |
0.416
|
|
|
|
trachea cartilage morphogenesis
|
GO:0060535 |
4 |
0.407
|
|
|
|
transmembrane receptor protein tyrosine kinase signaling pathway
|
GO:0007169 |
247 |
0.395
|
|
|
|
skeletal system development
|
GO:0001501 |
356 |
0.346
|
|
|
|
blood vessel morphogenesis
|
GO:0048514 |
285 |
0.337
|
|
|
|
forebrain development
|
GO:0030900 |
302 |
0.306
|
|
|
|
cell type specific apoptotic process
|
GO:0097285 |
268 |
0.302
|
|
|
|
muscle cell differentiation
|
GO:0042692 |
261 |
0.282
|
|
|
|
regulation of response to wounding
|
GO:1903034 |
189 |
0.277
|
|
|
|
skeletal system morphogenesis
|
GO:0048705 |
203 |
0.257
|
|
|
|
actin cytoskeleton organization
|
GO:0030036 |
220 |
0.256
|
|
|
|
positive regulation of transferase activity
|
GO:0051347 |
167 |
0.247
|
|
|
|
mapk cascade
|
GO:0000165 |
281 |
0.218
|
|
|
|
regulation of mapk cascade
|
GO:0043408 |
248 |
0.217
|
|
|
|
appendage morphogenesis
|
GO:0035107 |
149 |
0.206
|
|
|
|
cellular amine metabolic process
|
GO:0044106 |
44 |
0.205
|
|
|
|
regulation of cell activation
|
GO:0050865 |
289 |
0.202
|
|
|
|
blood coagulation
|
GO:0007596 |
76 |
0.201
|
|
|
|
respiratory tube development
|
GO:0030323 |
167 |
0.200
|
|
|
|
regeneration
|
GO:0031099 |
38 |
0.199
|
|
|
|
nucleoside phosphate metabolic process
|
GO:0006753 |
338 |
0.197
|
|
|
|
response to organic cyclic compound
|
GO:0014070 |
198 |
0.196
|
|
|
|
embryonic appendage morphogenesis
|
GO:0035113 |
126 |
0.195
|
|
|
|
planar cell polarity pathway involved in pericardium morphogenesis
|
GO:0061354 |
2 |
0.195
|
|
|
|
ossification
|
GO:0001503 |
216 |
0.188
|
|
|
|
spemann organizer formation
|
GO:0060061 |
2 |
0.186
|
|
|
|
single organism cell adhesion
|
GO:0098602 |
156 |
0.180
|
|
|
|
hypophysis morphogenesis
|
GO:0048850 |
3 |
0.178
|
|
|
|
regulation of inflammatory response
|
GO:0050727 |
147 |
0.174
|
|
|
|
response to oxygen levels
|
GO:0070482 |
62 |
0.172
|
|
|
|
response to organonitrogen compound
|
GO:0010243 |
246 |
0.172
|
|
|
|
gland development
|
GO:0048732 |
330 |
0.169
|
|
|
|
regulation of kinase activity
|
GO:0043549 |
249 |
0.168
|
|
|
|
mesenchyme development
|
GO:0060485 |
152 |
0.167
|
|
|
|
cartilage development
|
GO:0051216 |
140 |
0.163
|
|
|
|
leukocyte differentiation
|
GO:0002521 |
342 |
0.159
|
|
|
|
wnt signaling pathway involved in forebrain neuroblast division
|
GO:0021874 |
2 |
0.159
|
|
|
|
extracellular structure organization
|
GO:0043062 |
148 |
0.157
|
|
|
|
regulation of defense response
|
GO:0031347 |
233 |
0.156
|
|
|
|
cellular amino acid metabolic process
|
GO:0006520 |
103 |
0.155
|
|
|
|
jnk cascade
|
GO:0007254 |
72 |
0.155
|
|
|
|
lateral sprouting involved in mammary gland duct morphogenesis
|
GO:0060599 |
2 |
0.155
|
|
|
|
epithelial cell proliferation
|
GO:0050673 |
174 |
0.153
|
|
|
|
paraxial mesodermal cell differentiation
|
GO:0048342 |
2 |
0.152
|
|
|
|
inflammatory response
|
GO:0006954 |
244 |
0.152
|
|
|
|
positive regulation of protein modification process
|
GO:0031401 |
299 |
0.150
|
|
|
|
positive regulation of mapk cascade
|
GO:0043410 |
170 |
0.149
|
|
|
|
cellular homeostasis
|
GO:0019725 |
240 |
0.148
|
|
|
|
wound healing
|
GO:0042060 |
157 |
0.148
|
|
|
|
placenta development
|
GO:0001890 |
140 |
0.147
|
|
|
|
angiogenesis
|
GO:0001525 |
201 |
0.144
|
|
|
|
mesonephric tubule development
|
GO:0072164 |
94 |
0.143
|
|
|
|
ureteric bud development
|
GO:0001657 |
94 |
0.142
|
|
|
|
nephric duct formation
|
GO:0072179 |
4 |
0.142
|
|
|
|
mesonephros development
|
GO:0001823 |
97 |
0.141
|
|
|
|
organic hydroxy compound biosynthetic process
|
GO:1901617 |
77 |
0.141
|
|
|
|
limb development
|
GO:0060173 |
166 |
0.139
|
|
|
|
epithelial cell development
|
GO:0002064 |
159 |
0.138
|
|
|
|
camera type eye development
|
GO:0043010 |
266 |
0.136
|
|
|
|
small gtpase mediated signal transduction
|
GO:0007264 |
97 |
0.136
|
|
|
|
inner ear morphogenesis
|
GO:0042472 |
101 |
0.135
|
|
|
|
central nervous system neuron differentiation
|
GO:0021953 |
162 |
0.131
|
|
|
|
ras protein signal transduction
|
GO:0007265 |
77 |
0.131
|
|
|
|
nucleobase containing small molecule metabolic process
|
GO:0055086 |
352 |
0.128
|
|
|
|
membrane organization
|
GO:0061024 |
245 |
0.128
|
|
|
|
regulation of hormone levels
|
GO:0010817 |
211 |
0.128
|
|
|
|
planar cell polarity pathway involved in ventricular septum morphogenesis
|
GO:0061348 |
2 |
0.128
|
|
|
|
chondrocyte differentiation
|
GO:0002062 |
72 |
0.127
|
|
|
|
regulation of cellular amine metabolic process
|
GO:0033238 |
20 |
0.126
|
|
|
|
purine containing compound metabolic process
|
GO:0072521 |
311 |
0.124
|
|
|
|
transmembrane receptor protein serine threonine kinase signaling pathway
|
GO:0007178 |
194 |
0.124
|
|
|
|
protein maturation
|
GO:0051604 |
176 |
0.124
|
|
|
|
fat cell differentiation
|
GO:0045444 |
160 |
0.123
|
|
|
|
regulation of protein kinase activity
|
GO:0045859 |
232 |
0.122
|
|
|
|
positive regulation of protein kinase activity
|
GO:0045860 |
144 |
0.121
|
|
|
|
mesonephric duct formation
|
GO:0072181 |
2 |
0.121
|
|
|
|
amine metabolic process
|
GO:0009308 |
45 |
0.119
|
|
|
|
limb morphogenesis
|
GO:0035108 |
149 |
0.118
|
|
|
|
planar cell polarity pathway involved in cardiac muscle tissue morphogenesis
|
GO:0061350 |
2 |
0.117
|
|
|
|
bone development
|
GO:0060348 |
120 |
0.116
|
|
|
|
regionalization
|
GO:0003002 |
337 |
0.116
|
|
|
|
negative regulation of bmp signaling pathway
|
GO:0030514 |
35 |
0.116
|
|
|
|
ameboidal type cell migration
|
GO:0001667 |
128 |
0.114
|
|
|
|
wnt signaling pathway
|
GO:0016055 |
188 |
0.114
|
|
|
|
negative regulation of immune system process
|
GO:0002683 |
209 |
0.113
|
|
|
|
multicellular organism growth
|
GO:0035264 |
161 |
0.113
|
|
|
|
embryonic placenta development
|
GO:0001892 |
98 |
0.112
|
|
|
|
tissue remodeling
|
GO:0048771 |
102 |
0.112
|
|
|
|
glial cell differentiation
|
GO:0010001 |
131 |
0.111
|
|
|
|
positive regulation of cytoskeleton organization
|
GO:0051495 |
49 |
0.110
|
|
|
|
regulation of lymphocyte activation
|
GO:0051249 |
240 |
0.108
|
|
|
|
urogenital system development
|
GO:0001655 |
261 |
0.108
|
|
|
|
lymphocyte differentiation
|
GO:0030098 |
242 |
0.107
|
|
|
|
midgut development
|
GO:0007494 |
4 |
0.106
|
|
|
|
epidermis morphogenesis
|
GO:0048730 |
33 |
0.105
|
|
|
|
regulation of cellular response to stress
|
GO:0080135 |
159 |
0.104
|
|
|
|
regulation of cellular amino acid metabolic process
|
GO:0006521 |
5 |
0.102
|
|
|
|
purine ribonucleoside triphosphate catabolic process
|
GO:0009207 |
199 |
0.102
|
|
|
|
nucleotide metabolic process
|
GO:0009117 |
332 |
0.102
|
|
|
|
branching involved in ureteric bud morphogenesis
|
GO:0001658 |
56 |
0.101
|
|
|
|
lung development
|
GO:0030324 |
164 |
0.101
|
|
|
|
cellular protein complex assembly
|
GO:0043623 |
116 |
0.101
|
|
|
|
skin development
|
GO:0043588 |
220 |
0.101
|
|
|
|
morphogenesis of a polarized epithelium
|
GO:0001738 |
37 |
0.100
|
|
|
|
negative regulation of transmembrane receptor protein serine threonine kinase signaling pathway
|
GO:0090101 |
61 |
0.100
|
|
|
|
positive regulation of protein phosphorylation
|
GO:0001934 |
242 |
0.100
|
|
|
|
regulation of cell adhesion
|
GO:0030155 |
154 |
0.099
|
|
|
|
branching morphogenesis of an epithelial tube
|
GO:0048754 |
159 |
0.099
|
|
|
|
nephron development
|
GO:0072006 |
109 |
0.098
|
|
|
|
positive regulation of epithelial cell proliferation involved in lung morphogenesis
|
GO:0060501 |
3 |
0.098
|
|
|
|
actin filament bundle assembly
|
GO:0051017 |
40 |
0.097
|
|
|
|
developmental maturation
|
GO:0021700 |
193 |
0.097
|
|
|
|
mesonephric duct morphogenesis
|
GO:0072180 |
4 |
0.096
|
|
|
|
circulatory system process
|
GO:0003013 |
197 |
0.096
|
|
|
|
lung morphogenesis
|
GO:0060425 |
50 |
0.095
|
|
|
|
epithelial tube morphogenesis
|
GO:0060562 |
303 |
0.095
|
|
|
|
planar cell polarity pathway involved in outflow tract morphogenesis
|
GO:0061347 |
2 |
0.095
|
|
|
|
regulation of cellular ketone metabolic process
|
GO:0010565 |
66 |
0.095
|
|
|
|
protein modification by small protein conjugation
|
GO:0032446 |
187 |
0.095
|
|
|
|
actomyosin structure organization
|
GO:0031032 |
56 |
0.095
|
|
|
|
bone mineralization
|
GO:0030282 |
54 |
0.094
|
|
|
|
respiratory system development
|
GO:0060541 |
190 |
0.093
|
|
|
|
regulation of homeostatic process
|
GO:0032844 |
182 |
0.093
|
|
|
|
regulation of transferase activity
|
GO:0051338 |
263 |
0.093
|
|
|
|
thyroid stimulating hormone secreting cell differentiation
|
GO:0060129 |
4 |
0.092
|
|
|
|
positive regulation of apoptotic process
|
GO:0043065 |
217 |
0.091
|
|
|
|
positive regulation of map kinase activity
|
GO:0043406 |
84 |
0.090
|
|
|
|
organic acid biosynthetic process
|
GO:0016053 |
86 |
0.090
|
|
|
|
negative regulation of response to wounding
|
GO:1903035 |
77 |
0.090
|
|
|
|
axis elongation involved in somitogenesis
|
GO:0090245 |
4 |
0.090
|
|
|
|
blood circulation
|
GO:0008015 |
195 |
0.090
|
|
|
|
synapse assembly
|
GO:0007416 |
56 |
0.090
|
|
|
|
positive regulation of protein serine threonine kinase activity
|
GO:0071902 |
106 |
0.089
|
|
|
|
negative regulation of synapse assembly
|
GO:0051964 |
3 |
0.088
|
|
|
|
t cell activation
|
GO:0042110 |
289 |
0.088
|
|
|
|
ribose phosphate metabolic process
|
GO:0019693 |
291 |
0.088
|
|
|
|
regulation of stem cell proliferation
|
GO:0072091 |
78 |
0.087
|
|
|
|
regulation of wnt signaling pathway
|
GO:0030111 |
123 |
0.087
|
|
|
|
morphogenesis of a branching epithelium
|
GO:0061138 |
193 |
0.086
|
|
|
|
positive regulation of lymphocyte activation
|
GO:0051251 |
140 |
0.086
|
|
|
|
germ cell development
|
GO:0007281 |
185 |
0.086
|
|
|
|
positive regulation of kinase activity
|
GO:0033674 |
155 |
0.086
|
|
|
|
non canonical wnt signaling pathway via mapk cascade
|
GO:0038030 |
3 |
0.085
|
|
|
|
kidney development
|
GO:0001822 |
213 |
0.085
|
|
|
|
positive regulation of programmed cell death
|
GO:0043068 |
218 |
0.085
|
|
|
|
connective tissue development
|
GO:0061448 |
179 |
0.085
|
|
|
|
regulation of protein serine threonine kinase activity
|
GO:0071900 |
157 |
0.083
|
|
|
|
renal inner medulla development
|
GO:0072053 |
3 |
0.082
|
|
|
|
regulation of proteolysis
|
GO:0030162 |
164 |
0.082
|
|
|
|
embryonic organ morphogenesis
|
GO:0048562 |
276 |
0.082
|
|
|
|
regulation of ossification
|
GO:0030278 |
112 |
0.082
|
|
|
|
positive regulation of nervous system development
|
GO:0051962 |
221 |
0.081
|
|
|
|
oxygen homeostasis
|
GO:0032364 |
2 |
0.080
|
|
|
|
determination of heart left right asymmetry
|
GO:0061371 |
48 |
0.080
|
|
|
|
polarity specification of proximal distal axis
|
GO:0010085 |
2 |
0.080
|
|
|
|
telencephalon development
|
GO:0021537 |
186 |
0.079
|
|
|
|
cell maturation
|
GO:0048469 |
127 |
0.079
|
|
|
|
appendage development
|
GO:0048736 |
166 |
0.079
|
|
|
|
organic cyclic compound catabolic process
|
GO:1901361 |
295 |
0.079
|
|
|
|
regulation of apoptotic signaling pathway
|
GO:2001233 |
197 |
0.079
|
|
|
|
positive regulation of cell death
|
GO:0010942 |
224 |
0.078
|
|
|
|
chemotaxis
|
GO:0006935 |
247 |
0.078
|
|
|
|
kidney morphogenesis
|
GO:0060993 |
83 |
0.078
|
|
|
|
cofactor transport
|
GO:0051181 |
4 |
0.078
|
|
|
|
negative regulation of cellular response to growth factor stimulus
|
GO:0090288 |
46 |
0.077
|
|
|
|
protein catabolic process
|
GO:0030163 |
221 |
0.077
|
|
|
|
skeletal muscle satellite cell maintenance involved in skeletal muscle regeneration
|
GO:0014834 |
3 |
0.077
|
|
|
|
response to growth factor
|
GO:0070848 |
198 |
0.077
|
|
|
|
tissue regeneration
|
GO:0042246 |
22 |
0.076
|
|
|
|
cellular chemical homeostasis
|
GO:0055082 |
215 |
0.076
|
|
|
|
establishment of planar polarity involved in nephron morphogenesis
|
GO:0072046 |
1 |
0.075
|
|
|
|
i kappab kinase nf kappab signaling
|
GO:0007249 |
85 |
0.075
|
|
|
|
calcium ion homeostasis
|
GO:0055074 |
127 |
0.075
|
|
|
|
negative regulation of inflammatory response
|
GO:0050728 |
61 |
0.073
|
|
|
|
regulation of fibroblast growth factor production
|
GO:0090270 |
4 |
0.073
|
|
|
|
endothelial cell migration
|
GO:0043542 |
44 |
0.073
|
|
|
|
inner medullary collecting duct development
|
GO:0072061 |
2 |
0.072
|
|
|
|
metal ion homeostasis
|
GO:0055065 |
189 |
0.072
|
|
|
|
negative regulation of cellular protein metabolic process
|
GO:0032269 |
247 |
0.072
|
|
|
|
cellular ketone metabolic process
|
GO:0042180 |
84 |
0.072
|
|
|
|
morphogenesis of a branching structure
|
GO:0001763 |
203 |
0.071
|
|
|
|
kidney epithelium development
|
GO:0072073 |
121 |
0.071
|
|
|
|
response to inorganic substance
|
GO:0010035 |
96 |
0.070
|
|
|
|
regulation of stress activated mapk cascade
|
GO:0032872 |
69 |
0.070
|
|
|
|
ubiquitin dependent smad protein catabolic process
|
GO:0030579 |
2 |
0.070
|
|
|
|
regulation of canonical wnt signaling pathway involved in controlling type b pancreatic cell proliferation
|
GO:2000079 |
1 |
0.070
|
|
|
|
skeletal muscle cell differentiation
|
GO:0035914 |
66 |
0.070
|
|
|
|
renal vesicle induction
|
GO:0072034 |
3 |
0.070
|
|
|
|
establishment of organ orientation
|
GO:0048561 |
1 |
0.069
|
|
|
|
cellular response to cytokine stimulus
|
GO:0071345 |
189 |
0.069
|
|
|
|
defense response to other organism
|
GO:0098542 |
197 |
0.069
|
Fly |
|
|
positive regulation of cell adhesion
|
GO:0045785 |
80 |
0.069
|
|
|
|
purine nucleotide metabolic process
|
GO:0006163 |
302 |
0.068
|
|
|
|
cytokine production
|
GO:0001816 |
319 |
0.068
|
|
|
|
hair follicle development
|
GO:0001942 |
85 |
0.067
|
|
|
|
non canonical wnt signaling pathway via jnk cascade
|
GO:0038031 |
3 |
0.067
|
|
|
|
regulation of cartilage development
|
GO:0061035 |
44 |
0.067
|
|
|
|
mammary gland morphogenesis
|
GO:0060443 |
54 |
0.066
|
|
|
|
positive regulation of proteolysis
|
GO:0045862 |
85 |
0.066
|
|
|
|
regulation of morphogenesis of a branching structure
|
GO:0060688 |
53 |
0.065
|
|
|
|
lung induction
|
GO:0060492 |
3 |
0.065
|
|
|
|
regulation of cell motility
|
GO:2000145 |
236 |
0.065
|
|
|
|
central nervous system vasculogenesis
|
GO:0022009 |
3 |
0.064
|
|
|
|
skeletal muscle organ development
|
GO:0060538 |
163 |
0.064
|
|
|
|
foregut regionalization
|
GO:0060423 |
3 |
0.064
|
|
|
|
embryonic limb morphogenesis
|
GO:0030326 |
126 |
0.064
|
|
|
|
positive regulation of actin filament bundle assembly
|
GO:0032233 |
11 |
0.064
|
|
|
|
cation homeostasis
|
GO:0055080 |
212 |
0.064
|
|
|
|
regulation of cell migration
|
GO:0030334 |
219 |
0.064
|
|
|
|
ear development
|
GO:0043583 |
200 |
0.064
|
|
|
|
cellular response to oxidative stress
|
GO:0034599 |
76 |
0.063
|
|
|
|
stress activated mapk cascade
|
GO:0051403 |
80 |
0.063
|
|
|
|
regulation of body fluid levels
|
GO:0050878 |
162 |
0.063
|
|
|
|
uterus morphogenesis
|
GO:0061038 |
2 |
0.063
|
|
|
|
myeloid cell differentiation
|
GO:0030099 |
233 |
0.062
|
|
|
|
morphogenesis of an epithelial fold
|
GO:0060571 |
28 |
0.062
|
|
|
|
cerebellum formation
|
GO:0021588 |
1 |
0.062
|
|
|
|
development of primary sexual characteristics
|
GO:0045137 |
143 |
0.062
|
|
|
|
regulation of nucleotide metabolic process
|
GO:0006140 |
169 |
0.062
|
|
|
|
tissue migration
|
GO:0090130 |
68 |
0.062
|
|
|
|
digestive system development
|
GO:0055123 |
200 |
0.061
|
|
|
|
bronchiole development
|
GO:0060435 |
3 |
0.061
|
|
|
|
regulation of neuron apoptotic process
|
GO:0043523 |
122 |
0.060
|
|
|
|
gliogenesis
|
GO:0042063 |
141 |
0.060
|
|
|
|
cell proliferation in external granule layer
|
GO:0021924 |
10 |
0.060
|
|
|
|
regulation of synapse assembly
|
GO:0051963 |
29 |
0.060
|
|
|
|
rho protein signal transduction
|
GO:0007266 |
32 |
0.059
|
|
|
|
regulation of map kinase activity
|
GO:0043405 |
120 |
0.059
|
|
|
|
positive regulation of cellular component biogenesis
|
GO:0044089 |
94 |
0.059
|
|
|
|
hair follicle morphogenesis
|
GO:0031069 |
29 |
0.059
|
|
|
|
male gamete generation
|
GO:0048232 |
285 |
0.058
|
|
|
|
response to peptide
|
GO:1901652 |
136 |
0.058
|
|
|
|
purine ribonucleoside triphosphate metabolic process
|
GO:0009205 |
220 |
0.058
|
|
|
|
regulation of vasculature development
|
GO:1901342 |
88 |
0.058
|
|
|
|
regulation of actin cytoskeleton organization
|
GO:0032956 |
84 |
0.058
|
|
|
|
macromolecule catabolic process
|
GO:0009057 |
281 |
0.058
|
|
|
|
mammary gland epithelium development
|
GO:0061180 |
65 |
0.058
|
|
|
|
purine ribonucleotide metabolic process
|
GO:0009150 |
290 |
0.058
|
|
|
|
organonitrogen compound biosynthetic process
|
GO:1901566 |
192 |
0.058
|
|
|
|
regulation of cell cell adhesion mediated by cadherin
|
GO:2000047 |
2 |
0.058
|
|
|
|
oxidation reduction process
|
GO:0055114 |
342 |
0.057
|
|
|
|
bmp signaling pathway
|
GO:0030509 |
93 |
0.057
|
|
|
|
paramesonephric duct development
|
GO:0061205 |
3 |
0.057
|
|
|
|
digestive tract development
|
GO:0048565 |
190 |
0.057
|
|
|
|
interleukin 8 production
|
GO:0032637 |
4 |
0.057
|
|
|
|
mesenchymal epithelial cell signaling
|
GO:0060638 |
9 |
0.057
|
|
|
|
negative regulation of cell migration
|
GO:0030336 |
59 |
0.057
|
|
|
|
response to metal ion
|
GO:0010038 |
47 |
0.057
|
|
|
|
heterocycle catabolic process
|
GO:0046700 |
280 |
0.056
|
|
|
|
morphogenesis of embryonic epithelium
|
GO:0016331 |
159 |
0.056
|
|
|
|
syncytiotrophoblast cell differentiation involved in labyrinthine layer development
|
GO:0060715 |
2 |
0.056
|
|
|
|
bone morphogenesis
|
GO:0060349 |
78 |
0.056
|
|
|
|
wnt signaling pathway planar cell polarity pathway
|
GO:0060071 |
27 |
0.056
|
|
|
|
purine containing compound catabolic process
|
GO:0072523 |
213 |
0.056
|
|
|
|
spermatogenesis
|
GO:0007283 |
284 |
0.056
|
|
|
|
endochondral bone morphogenesis
|
GO:0060350 |
50 |
0.056
|
|
|
|
extracellular matrix organization
|
GO:0030198 |
147 |
0.056
|
|
|
|
stem cell proliferation
|
GO:0072089 |
117 |
0.055
|
|
|
|
lipid biosynthetic process
|
GO:0008610 |
179 |
0.055
|
|
|
|
t cell differentiation in thymus
|
GO:0033077 |
77 |
0.055
|
|
|
|
nephron tubule morphogenesis
|
GO:0072078 |
68 |
0.055
|
|
|
|
small molecule biosynthetic process
|
GO:0044283 |
132 |
0.055
|
|
|
|
embryonic skeletal system morphogenesis
|
GO:0048704 |
91 |
0.055
|
|
|
|
multi multicellular organism process
|
GO:0044706 |
109 |
0.055
|
|
|
|
planar cell polarity pathway involved in heart morphogenesis
|
GO:0061346 |
3 |
0.054
|
|
|
|
regulation of cytoskeleton organization
|
GO:0051493 |
122 |
0.054
|
|
|
|
regulation of canonical wnt signaling pathway
|
GO:0060828 |
82 |
0.054
|
|
|
|
positive regulation of cardiac muscle tissue growth
|
GO:0055023 |
15 |
0.054
|
|
|
|
endocytosis
|
GO:0006897 |
168 |
0.054
|
|
|
|
purine ribonucleoside catabolic process
|
GO:0046130 |
205 |
0.054
|
|
|
|
lung alveolus development
|
GO:0048286 |
45 |
0.054
|
|
|
|
positive regulation of secretion by cell
|
GO:1903532 |
114 |
0.053
|
|
|
|
ureteric bud morphogenesis
|
GO:0060675 |
62 |
0.053
|
|
|
|
protein processing
|
GO:0016485 |
163 |
0.053
|
|
|
|
regulation of bmp signaling pathway
|
GO:0030510 |
60 |
0.052
|
|
|
|
testosterone biosynthetic process
|
GO:0061370 |
2 |
0.052
|
|
|
|
apoptotic signaling pathway
|
GO:0097190 |
306 |
0.052
|
|
|
|
positive regulation of ossification
|
GO:0045778 |
47 |
0.052
|
|
|
|
mammary gland duct morphogenesis
|
GO:0060603 |
38 |
0.052
|
|
|
|
negative regulation of cytokine production
|
GO:0001818 |
84 |
0.052
|
|
|
|
nucleoside triphosphate metabolic process
|
GO:0009141 |
230 |
0.052
|
|
|
|
nephron tubule development
|
GO:0072080 |
84 |
0.051
|
|
|
|
cellular response to hormone stimulus
|
GO:0032870 |
150 |
0.051
|
|
|
|
odontogenesis
|
GO:0042476 |
78 |
0.051
|
|
|
|
response to extracellular stimulus
|
GO:0009991 |
127 |
0.051
|
|
|
|
forebrain generation of neurons
|
GO:0021872 |
63 |
0.051
|
|
|
|
mesenchymal cell differentiation
|
GO:0048762 |
107 |
0.051
|
|
|
|
central nervous system morphogenesis
|
GO:0021551 |
2 |
0.051
|
|
|
|
epithelium migration
|
GO:0090132 |
63 |
0.051
|
|
|
|
midbrain hindbrain boundary maturation
|
GO:0021732 |
1 |
0.051
|
|
|
|
establishment of planar polarity
|
GO:0001736 |
28 |
0.051
|
|
|
|
non canonical wnt signaling pathway
|
GO:0035567 |
33 |
0.050
|
|
|
|
purine nucleotide catabolic process
|
GO:0006195 |
211 |
0.050
|
|
|
|
regulation of organelle organization
|
GO:0033043 |
289 |
0.050
|
|
|
|
response to decreased oxygen levels
|
GO:0036293 |
59 |
0.049
|
|
|
|
cellular response to cadmium ion
|
GO:0071276 |
3 |
0.049
|
|
|
|
cellular response to growth factor stimulus
|
GO:0071363 |
197 |
0.049
|
|
|
|
cellular metal ion homeostasis
|
GO:0006875 |
151 |
0.049
|
|
|
|
skin morphogenesis
|
GO:0043589 |
38 |
0.049
|
|
|
|
regulation of cellular component biogenesis
|
GO:0044087 |
181 |
0.049
|
|
|
|
epidermis development
|
GO:0008544 |
187 |
0.049
|
|
|
|
androgen biosynthetic process
|
GO:0006702 |
4 |
0.049
|
|
|
|
positive regulation of cellular amine metabolic process
|
GO:0033240 |
5 |
0.049
|
|
|
|
regulation of angiogenesis
|
GO:0045765 |
81 |
0.049
|
|
|
|
axon guidance
|
GO:0007411 |
141 |
0.049
|
|
|
|
cytokine mediated signaling pathway
|
GO:0019221 |
115 |
0.049
|
|
|
|
synapse organization
|
GO:0050808 |
125 |
0.048
|
|
|
|
cervix development
|
GO:0060067 |
2 |
0.048
|
|
|
|
regulation of establishment of planar polarity
|
GO:0090175 |
28 |
0.048
|
|
|
|
planar cell polarity pathway involved in cardiac right atrium morphogenesis
|
GO:0061349 |
2 |
0.048
|
|
|
|
mesonephric tubule morphogenesis
|
GO:0072171 |
63 |
0.048
|
|
|
|
peptidyl amino acid modification
|
GO:0018193 |
336 |
0.048
|
|
|
|
reactive oxygen species metabolic process
|
GO:0072593 |
84 |
0.048
|
|
|
|
carboxylic acid biosynthetic process
|
GO:0046394 |
86 |
0.047
|
|
|
|
positive regulation of transforming growth factor beta2 production
|
GO:0032915 |
2 |
0.047
|
|
|
|
response to hypoxia
|
GO:0001666 |
58 |
0.047
|
|
|
|
mesonephric epithelium development
|
GO:0072163 |
94 |
0.047
|
|
|
|
cardiac septum morphogenesis
|
GO:0060411 |
46 |
0.047
|
|
|
|
kidney rudiment formation
|
GO:0072003 |
3 |
0.047
|
|
|
|
stem cell differentiation
|
GO:0048863 |
268 |
0.047
|
|
|
|
regulation of cellular response to growth factor stimulus
|
GO:0090287 |
82 |
0.047
|
|
|
|
canonical wnt signaling pathway
|
GO:0060070 |
130 |
0.047
|
|
|
|
stem cell development
|
GO:0048864 |
219 |
0.047
|
|
|
|
hematopoietic progenitor cell differentiation
|
GO:0002244 |
143 |
0.046
|
|
|
|
embryonic digit morphogenesis
|
GO:0042733 |
56 |
0.046
|
|
|
|
positive regulation of cell activation
|
GO:0050867 |
158 |
0.046
|
|
|
|
hindbrain formation
|
GO:0021576 |
1 |
0.046
|
|
|
|
endocrine system development
|
GO:0035270 |
98 |
0.046
|
|
|
|
negative regulation of nervous system development
|
GO:0051961 |
156 |
0.046
|
|
|
|
divalent inorganic cation homeostasis
|
GO:0072507 |
138 |
0.045
|
|
|
|
regulation of testosterone biosynthetic process
|
GO:2000224 |
2 |
0.045
|
|
|
|
neuron apoptotic process
|
GO:0051402 |
142 |
0.045
|
|
|
|
outer medullary collecting duct development
|
GO:0072060 |
1 |
0.045
|
|
|
|
regulation of hydrolase activity
|
GO:0051336 |
246 |
0.045
|
|
|
|
female sex differentiation
|
GO:0046660 |
84 |
0.045
|
|
|
|
positive regulation of canonical wnt signaling pathway involved in controlling type b pancreatic cell proliferation
|
GO:2000081 |
1 |
0.045
|
|
|
|
regulation of peptidyl serine phosphorylation
|
GO:0033135 |
39 |
0.045
|
|
|
|
negative regulation of mesenchymal cell proliferation
|
GO:0072201 |
3 |
0.045
|
|
|
|
neuron projection extension
|
GO:1990138 |
64 |
0.045
|
|
|
|
odontogenesis of dentin containing tooth
|
GO:0042475 |
66 |
0.044
|
|
|
|
cellular response to lipid
|
GO:0071396 |
145 |
0.044
|
|
|
|
purine nucleoside metabolic process
|
GO:0042278 |
241 |
0.044
|
|
|
|
cellular lipid metabolic process
|
GO:0044255 |
323 |
0.044
|
|
|
|
tertiary branching involved in mammary gland duct morphogenesis
|
GO:0060748 |
3 |
0.044
|
|
|
|
muscle tissue development
|
GO:0060537 |
308 |
0.044
|
|
|
|
regulation of establishment of protein localization
|
GO:0070201 |
181 |
0.044
|
|
|
|
cellular response to extracellular stimulus
|
GO:0031668 |
81 |
0.044
|
|
|
|
embryonic skeletal system development
|
GO:0048706 |
120 |
0.044
|
|
|
|
negative regulation of androgen biosynthetic process
|
GO:2000180 |
1 |
0.043
|
|
|
|
positive regulation of cell cell adhesion mediated by cadherin
|
GO:2000049 |
2 |
0.043
|
|
|
|
protein modification by small protein conjugation or removal
|
GO:0070647 |
207 |
0.043
|
|
|
|
anatomical structure homeostasis
|
GO:0060249 |
145 |
0.043
|
|
|
|
positive regulation of t cell activation
|
GO:0050870 |
101 |
0.043
|
|
|
|
regulation of anagen
|
GO:0051884 |
1 |
0.043
|
|
|
|
positive regulation of interleukin 8 production
|
GO:0032757 |
2 |
0.043
|
|
|
|
purine nucleoside catabolic process
|
GO:0006152 |
205 |
0.043
|
|
|
|
t cell apoptotic process
|
GO:0070231 |
39 |
0.042
|
|
|
|
cellular response to insulin stimulus
|
GO:0032869 |
78 |
0.042
|
|
|
|
developmental growth involved in morphogenesis
|
GO:0060560 |
138 |
0.042
|
|
|
|
hindbrain development
|
GO:0030902 |
128 |
0.042
|
|
|
|
hemostasis
|
GO:0007599 |
78 |
0.042
|
|
|
|
neuron death
|
GO:0070997 |
154 |
0.042
|
|
|
|
digestive tract morphogenesis
|
GO:0048546 |
147 |
0.042
|
|
|
|
positive regulation of apoptotic signaling pathway
|
GO:2001235 |
95 |
0.041
|
|
|
|
steroid metabolic process
|
GO:0008202 |
119 |
0.041
|
|
|
|
myoblast differentiation involved in skeletal muscle regeneration
|
GO:0014835 |
3 |
0.041
|
|
|
|
cellular response to organonitrogen compound
|
GO:0071417 |
145 |
0.041
|
|
|
|
non canonical wnt signaling pathway involved in heart development
|
GO:0061341 |
3 |
0.041
|
|
|
|
stress activated protein kinase signaling cascade
|
GO:0031098 |
81 |
0.040
|
|
|
|
positive regulation of cytokine production
|
GO:0001819 |
174 |
0.040
|
|
|
|
fibroblast growth factor production
|
GO:0090269 |
4 |
0.040
|
|
|
|
regulation of cysteine type endopeptidase activity involved in apoptotic process
|
GO:0043281 |
62 |
0.040
|
|
|
|
gas homeostasis
|
GO:0033483 |
3 |
0.040
|
|
|
|
nucleotide catabolic process
|
GO:0009166 |
217 |
0.039
|
|
|
|
dendrite development
|
GO:0016358 |
115 |
0.039
|
|
|
|
actin filament organization
|
GO:0007015 |
113 |
0.039
|
|
|
|
monocarboxylic acid biosynthetic process
|
GO:0072330 |
61 |
0.039
|
|
|
|
response to peptide hormone
|
GO:0043434 |
127 |
0.039
|
|
|
|
lung field specification
|
GO:0060424 |
3 |
0.039
|
|
|
|
cell adhesion
|
GO:0007155 |
329 |
0.039
|
|
|
|
maintenance of location
|
GO:0051235 |
89 |
0.039
|
|
|
|
cellular divalent inorganic cation homeostasis
|
GO:0072503 |
127 |
0.039
|
|
|
|
establishment of tissue polarity
|
GO:0007164 |
28 |
0.039
|
|
|
|
cellular response to peptide
|
GO:1901653 |
92 |
0.038
|
|
|
|
midbrain hindbrain boundary maturation during brain development
|
GO:0022004 |
1 |
0.038
|
|
|
|
response to amino acid
|
GO:0043200 |
37 |
0.038
|
|
|
|
regulation of peptidase activity
|
GO:0052547 |
96 |
0.038
|
|
|
|
negative regulation of protein maturation
|
GO:1903318 |
79 |
0.038
|
|
|
|
somatic stem cell maintenance
|
GO:0035019 |
47 |
0.038
|
|
|
|
protein ubiquitination
|
GO:0016567 |
171 |
0.038
|
|
|
|
positive regulation of cell development
|
GO:0010720 |
237 |
0.037
|
|
|
|
methylation
|
GO:0032259 |
134 |
0.037
|
|
|
|
heart process
|
GO:0003015 |
94 |
0.037
|
|
|
|
male sex differentiation
|
GO:0046661 |
109 |
0.037
|
|
|
|
cellular response to organic cyclic compound
|
GO:0071407 |
87 |
0.037
|
|
|
|
purine nucleoside triphosphate catabolic process
|
GO:0009146 |
203 |
0.037
|
|
|
|
protein localization to membrane
|
GO:0072657 |
108 |
0.037
|
|
|
|
peripheral nervous system development
|
GO:0007422 |
53 |
0.037
|
|
|
|
neuron projection extension involved in neuron projection guidance
|
GO:1902284 |
14 |
0.037
|
|
|
|
cell junction organization
|
GO:0034330 |
77 |
0.037
|
|
|
|
ribonucleoside triphosphate metabolic process
|
GO:0009199 |
220 |
0.037
|
|
|
|
cell division
|
GO:0051301 |
120 |
0.036
|
|
|
|
negative regulation of neuron death
|
GO:1901215 |
98 |
0.036
|
|
|
|
positive regulation of anagen
|
GO:0051885 |
1 |
0.036
|
|
|
|
negative regulation of canonical wnt signaling pathway
|
GO:0090090 |
51 |
0.036
|
|
|
|
ion transmembrane transport
|
GO:0034220 |
361 |
0.036
|
|
|
|
positive regulation of rna polymerase ii transcriptional preinitiation complex assembly
|
GO:0045899 |
2 |
0.036
|
|
|
|
nucleoside catabolic process
|
GO:0009164 |
206 |
0.036
|
|
|
|
regulation of fat cell differentiation
|
GO:0045598 |
81 |
0.036
|
|
|
|
learning or memory
|
GO:0007611 |
148 |
0.036
|
|
|
|
retina development in camera type eye
|
GO:0060041 |
119 |
0.036
|
|
|
|
locomotory behavior
|
GO:0007626 |
195 |
0.036
|
|
|
|
regulation of sequence specific dna binding transcription factor activity
|
GO:0051090 |
106 |
0.036
|
|
|
|
cerebellar granule cell precursor proliferation
|
GO:0021930 |
10 |
0.036
|
|
|
|
negative regulation of testosterone biosynthetic process
|
GO:2000225 |
1 |
0.036
|
|
|
|
myeloid cell homeostasis
|
GO:0002262 |
114 |
0.036
|
|
|
|
carbohydrate homeostasis
|
GO:0033500 |
128 |
0.035
|
|
|
|
negative regulation of cellular component organization
|
GO:0051129 |
194 |
0.035
|
|
|
|
mesenchymal cell development
|
GO:0014031 |
93 |
0.035
|
|
|
|
positive regulation of synapse assembly
|
GO:0051965 |
18 |
0.035
|
|
|
|
renal outer medulla development
|
GO:0072054 |
2 |
0.035
|
|
|
|
axonogenesis
|
GO:0007409 |
274 |
0.035
|
|
|
|
cell fate commitment
|
GO:0045165 |
210 |
0.035
|
|
|
|
organ induction
|
GO:0001759 |
21 |
0.035
|
|
|
|
cellular transition metal ion homeostasis
|
GO:0046916 |
32 |
0.034
|
|
|
|
type b pancreatic cell proliferation
|
GO:0044342 |
10 |
0.034
|
|
|
|
negative regulation of prostatic bud formation
|
GO:0060686 |
4 |
0.034
|
|
|
|
negative regulation of neuron projection development
|
GO:0010977 |
50 |
0.034
|
|
|
|
t cell differentiation
|
GO:0030217 |
174 |
0.034
|
|
|
|
purine ribonucleoside metabolic process
|
GO:0046128 |
241 |
0.034
|
|
|
|
neural tube closure
|
GO:0001843 |
90 |
0.034
|
|
|
|
cardiac right atrium morphogenesis
|
GO:0003213 |
3 |
0.034
|
|
|
|
lipid localization
|
GO:0010876 |
126 |
0.034
|
|
|
|
regulation of interleukin 6 production
|
GO:0032675 |
55 |
0.033
|
|
|
|
positive regulation of heart growth
|
GO:0060421 |
18 |
0.033
|
|
|
|
regulation of anatomical structure size
|
GO:0090066 |
178 |
0.033
|
|
|
|
regulation of mesenchymal cell proliferation
|
GO:0010464 |
37 |
0.033
|
|
|
|
protein localization to organelle
|
GO:0033365 |
185 |
0.033
|
|
|
|
bone remodeling
|
GO:0046849 |
53 |
0.033
|
|
|
|
somitogenesis
|
GO:0001756 |
69 |
0.033
|
|
|
|
body morphogenesis
|
GO:0010171 |
45 |
0.033
|
|
|
|
nephron epithelium morphogenesis
|
GO:0072088 |
68 |
0.032
|
|
|
|
epithelial to mesenchymal transition
|
GO:0001837 |
47 |
0.032
|
|
|
|
regulation of leukocyte differentiation
|
GO:1902105 |
159 |
0.032
|
|
|
|
ribonucleotide metabolic process
|
GO:0009259 |
291 |
0.032
|
|
|
|
positive regulation of cellular amino acid metabolic process
|
GO:0045764 |
3 |
0.032
|
|
|
|
regulation of jnk cascade
|
GO:0046328 |
62 |
0.032
|
|
|
|
tube closure
|
GO:0060606 |
91 |
0.032
|
|
|
|
lymphocyte apoptotic process
|
GO:0070227 |
54 |
0.032
|
|
|
|
intestinal epithelial cell maturation
|
GO:0060574 |
2 |
0.032
|
|
|
|
ear morphogenesis
|
GO:0042471 |
118 |
0.032
|
|
|
|
regulation of rho gtpase activity
|
GO:0032319 |
58 |
0.031
|
|
|
|
central nervous system neuron axonogenesis
|
GO:0021955 |
28 |
0.031
|
|
|
|
negative regulation of cell cycle
|
GO:0045786 |
123 |
0.031
|
|
|
|
negative regulation of catenin import into nucleus
|
GO:0035414 |
2 |
0.031
|
|
|
|
regulation of purine nucleotide metabolic process
|
GO:1900542 |
169 |
0.031
|
|
|
|
nucleoside phosphate catabolic process
|
GO:1901292 |
222 |
0.031
|
|
|
|
regulation of chondrocyte differentiation
|
GO:0032330 |
33 |
0.031
|
|
|
|
negative regulation of protein metabolic process
|
GO:0051248 |
282 |
0.031
|
|
|
|
regulation of nucleoside metabolic process
|
GO:0009118 |
130 |
0.031
|
|
|
|
negative regulation of epithelial cell proliferation
|
GO:0050680 |
64 |
0.031
|
|
|
|
glial cell development
|
GO:0021782 |
54 |
0.031
|
|
|
|
tongue development
|
GO:0043586 |
18 |
0.031
|
|
|
|
blastocyst development
|
GO:0001824 |
80 |
0.031
|
|
|
|
negative regulation of cartilage development
|
GO:0061037 |
17 |
0.031
|
|
|
|
regulation of muscle tissue development
|
GO:1901861 |
97 |
0.030
|
|
|
|
regulation of protein processing
|
GO:0070613 |
96 |
0.030
|
|
|
|
central nervous system neuron development
|
GO:0021954 |
67 |
0.030
|
|
|
|
positive regulation of organ growth
|
GO:0046622 |
29 |
0.030
|
|
|
|
cellular response to parathyroid hormone stimulus
|
GO:0071374 |
2 |
0.030
|
|
|
|
endothelial cell development
|
GO:0001885 |
20 |
0.030
|
|
|
|
purine nucleoside triphosphate metabolic process
|
GO:0009144 |
226 |
0.030
|
|
|
|
regulation of secretion
|
GO:0051046 |
274 |
0.030
|
|
|
|
response to fibroblast growth factor
|
GO:0071774 |
47 |
0.030
|
|
|
|
intracellular protein transport
|
GO:0006886 |
204 |
0.030
|
|
|
|
glycosyl compound catabolic process
|
GO:1901658 |
206 |
0.030
|
|
|
|
ribonucleoside triphosphate catabolic process
|
GO:0009203 |
199 |
0.030
|
|
|
|
neural precursor cell proliferation
|
GO:0061351 |
121 |
0.030
|
|
|
|
t cell proliferation
|
GO:0042098 |
120 |
0.029
|
|
|
|
establishment of endothelial blood brain barrier
|
GO:0014045 |
3 |
0.029
|
|
|
|
purine ribonucleotide catabolic process
|
GO:0009154 |
208 |
0.029
|
|
|
|
negative regulation of growth
|
GO:0045926 |
99 |
0.029
|
|
|
|
glycosyl compound metabolic process
|
GO:1901657 |
246 |
0.029
|
|
|
|
nucleoside metabolic process
|
GO:0009116 |
246 |
0.029
|
|
|
|
cell junction assembly
|
GO:0034329 |
52 |
0.029
|
|
|
|
gonad development
|
GO:0008406 |
141 |
0.029
|
|
|
|
embryonic digestive tract development
|
GO:0048566 |
27 |
0.029
|
|
|
|
regulation of rna polymerase ii transcriptional preinitiation complex assembly
|
GO:0045898 |
2 |
0.029
|
|
|
|
regulation of system process
|
GO:0044057 |
200 |
0.029
|
|
|
|
connective tissue replacement involved in inflammatory response wound healing
|
GO:0002248 |
3 |
0.029
|
|
|
|
gastrulation
|
GO:0007369 |
116 |
0.029
|
|
